WO2009093007A3 - Immune modulation by regioselectively modified glycosides - Google Patents
Immune modulation by regioselectively modified glycosides Download PDFInfo
- Publication number
- WO2009093007A3 WO2009093007A3 PCT/GB2009/000131 GB2009000131W WO2009093007A3 WO 2009093007 A3 WO2009093007 A3 WO 2009093007A3 GB 2009000131 W GB2009000131 W GB 2009000131W WO 2009093007 A3 WO2009093007 A3 WO 2009093007A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- immune modulation
- modified glycosides
- regioselectively modified
- regioselectively
- glycosides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
We describe the use of regioselectively glycosylated glycoside scaffolds in the modulation of the immune system.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0801032.4 | 2008-01-21 | ||
GBGB0801032.4A GB0801032D0 (en) | 2008-01-21 | 2008-01-21 | Immune modulation |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009093007A2 WO2009093007A2 (en) | 2009-07-30 |
WO2009093007A3 true WO2009093007A3 (en) | 2009-11-26 |
Family
ID=39166075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2009/000131 WO2009093007A2 (en) | 2008-01-21 | 2009-01-16 | Immune modulation by regioselectively modified glycosides |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0801032D0 (en) |
WO (1) | WO2009093007A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012086812A1 (en) * | 2010-12-22 | 2012-06-28 | 味の素株式会社 | Glycoside compound |
CN102949404B (en) * | 2011-08-16 | 2016-09-14 | 中国医学科学院药物研究所 | Vanillic acid glucoside derivative purposes in treatment of systemic autoimmune disease |
WO2013128423A1 (en) * | 2012-03-02 | 2013-09-06 | Institut National De La Sante Et De La Recherche Medicale | Use of a glycosylated-modified tetrafunctional non-ionic amphiphilic block copolymer as immune adjuvant |
KR101392988B1 (en) | 2012-09-13 | 2014-05-09 | 건국대학교 산학협력단 | Engineered Esherichia coli expressing uridine-diphosphate(UDP)-dependent glycosyltransferase and Synthesis of quercetin 3,7-di-O-rhamnoside from the same |
BR112015013651B1 (en) | 2012-12-27 | 2020-03-24 | Kimberly-Clark Worldwide, Inc. | FARNESOL ANALOG, SCARF, ABSORBENT ARTICLE, AND FORMATION METHOD OF A FARNESOL ANALOG |
WO2014101049A1 (en) | 2012-12-27 | 2014-07-03 | Kimberly-Clark Worldwide, Inc. | Water soluble essential oils and their use |
WO2015114584A1 (en) * | 2014-01-31 | 2015-08-06 | Ghimas S.P.A. | Polydatin for the treatment of hiv in patients |
WO2019135257A1 (en) | 2018-01-03 | 2019-07-11 | Council Of Scientific And Industrial Research | Artemisinic acid glycoconjugate compounds, process for preparation and use thereof |
US11643428B2 (en) * | 2018-02-06 | 2023-05-09 | Shanghai Pharmaceuticals Holding Co., Ltd. | Therapeutic drug for neurodegenerative disease and application thereof |
KR102187233B1 (en) * | 2018-12-07 | 2020-12-04 | 경희대학교 산학협력단 | Composition for immunity enhancement or anti-inflammatory comprising flavonoid from Brugmansia arborea |
CN111658631A (en) * | 2020-06-11 | 2020-09-15 | 广东盛普生命科技有限公司 | Application of gallic acid and its derivatives and structural analogs in preparing anti-coronavirus medicine |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002032410A2 (en) * | 2000-10-19 | 2002-04-25 | Imperial College Innovations Limited | Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders |
WO2007034190A2 (en) * | 2005-09-21 | 2007-03-29 | The University Of York | Regioselective glycosylation |
-
2008
- 2008-01-21 GB GBGB0801032.4A patent/GB0801032D0/en not_active Ceased
-
2009
- 2009-01-16 WO PCT/GB2009/000131 patent/WO2009093007A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002032410A2 (en) * | 2000-10-19 | 2002-04-25 | Imperial College Innovations Limited | Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders |
WO2007034190A2 (en) * | 2005-09-21 | 2007-03-29 | The University Of York | Regioselective glycosylation |
Non-Patent Citations (3)
Title |
---|
FENG YONG-HONG ET AL: "Low dose of resveratrol enhanced immune response of mice", ACTA PHARMACOLOGICA SINICA, WILEY INTERSCIENCE, vol. 23, no. 10, 1 October 2002 (2002-10-01), pages 893 - 897, XP002378877, ISSN: 1671-4083 * |
LAI-YI WANG ET AL: "Resveratrol glucuronides as the metabolites of resveratrol in humans: Characterization, synthesis, and anti-HIV activity", JOURNAL OF PHARMACEUTICAL SCIENCE, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, US, vol. 93, no. 10, 23 July 2004 (2004-07-23), pages 2448 - 2457, XP009120641, ISSN: 0022-3549 * |
LU WEI ET AL: "Therapeutic dendritic-cell vaccine for simian AIDS", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 9, no. 1, 1 January 2003 (2003-01-01), pages 27 - 32, XP002366697, ISSN: 1078-8956 * |
Also Published As
Publication number | Publication date |
---|---|
GB0801032D0 (en) | 2008-02-27 |
WO2009093007A2 (en) | 2009-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009093007A3 (en) | Immune modulation by regioselectively modified glycosides | |
IL211892A0 (en) | Pyrazolo pyridine derivatives, compositions comprising the same and uses thereof | |
IL211889A0 (en) | Pyrazolo pyridine derivatives, compositions comprising the same and uses thereof | |
EP2282788B8 (en) | See-through, reduced-pressure dressings and systems | |
EP2271401A4 (en) | Microcurrent-generating topical or cosmetic systems, and methods of making and using the same | |
WO2008073483A3 (en) | Methods and systems related to receiving nutraceutical associated information | |
AP2011005661A0 (en) | Unitised building system. | |
IL211891A0 (en) | Pyrazolo pyridine derivatives, compositions comprising the same and uses thereof | |
WO2010118866A8 (en) | Trehalulose-containing composition, its preparation and use | |
WO2011116256A3 (en) | Multiphase microarrays and uses thereof | |
EP2442864A4 (en) | Microcurrent-generating topical or cosmetic systems, and methods of making and using the same | |
WO2010005622A3 (en) | Telescoping devices | |
WO2010027590A3 (en) | Solution microarrays and uses thereof | |
WO2012021678A3 (en) | Isolated bacteria, methods for use, and methods for isolation | |
WO2011079312A3 (en) | Panel system | |
WO2008002640A3 (en) | Methods and systems for analysis of nutraceutical associated components | |
WO2011006566A3 (en) | Monomethoxy-hydroxy-benzylmalonate diesters | |
AU2008901568A0 (en) | Improvements in, or relating to furniture | |
AU2008100909A4 (en) | The Challenge of ............ | |
AU2008904155A0 (en) | Hang Glider Lift Augmentation System | |
AU2008901421A0 (en) | Hang Glider Lift Augmentation System | |
AU2008903539A0 (en) | Shelving System | |
AU2008903010A0 (en) | The Levy-traction system | |
GB0805117D0 (en) | System and method for improving the efficiency, comfort, and/or reliability in operating systems, such as for example windows | |
GB0823346D0 (en) | System and method for improving the efficiency, comfort, and/or reliability in operating systems, such as for example Windows |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09703646 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09703646 Country of ref document: EP Kind code of ref document: A2 |